Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,068.80down ₹28.70 (2.62%)BSE ₹1,069.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,097.50.
30 Oct: open ₹1,050.00, high ₹1,076.90, low ₹972.00
52-week range of traded prices to 30 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,851 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.47%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 26,77,98551.0% delivered
Strides Pharma Science dividends
26 filed, newest first.
May 2024
May 2023
May 2021
Jul 2020
May 2020
Jul 2019
May 2019
May 2018
May 2017
May 2016
May 2015
22 May · Dividend
Board of Directors at its meeting held on May 22, 2015, has recommended dividend at 30% viz., Rs. 3/- per share for the year ended March 31, 2015.
Oct 2014
7 Oct · Dividend
Special Dividend will be paid on or after October 22, 2014.7 Oct · Dividend
Board of Directors at its meeting held on October 07, 2014 have approved a Special Dividend of Rs.105/- (Rupees One Hundred Five Only) per equity share of Rs.10/- each to the shareholders of the Company.
Sep 2014
12 Sep · Dividend
Dividend payout date shall be on or after September 17, 2014.
Dec 2013
10 Dec · Dividend
Board of Directors of the Company at its meeting held on December 10, 2013 have approved a Special Dividend of Rs.500/- (Rupees Five Hundred Only) per equity share of Rs.10/- each to the shareholders of the Company.10 Dec · Dividend
Special dividend will be paid on or after December 27, 2013.
Jun 2013
5 Jun · Dividend
Strides Arcolab Limited had informed the Exchange on February 28, 2013 that the dividend payout date will be June 05, 2013, subject to the approval of dividend by the shareholders of the Company at the ensuing Annual General Meeting on May 31, 2013. The Company has now informed the Exchange that the dividend payout date for the financial year ended December 31, 2012 stands revised to June 17, 2013. Payment of dividend will be subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting on June 10, 2013.
Feb 2013
28 Feb · Dividend
Dividend payout date will be June 05, 2013, subject to the approval of dividend by the shareholders of the Company at the ensuing Annual General Meeting on May 31, 2013.28 Feb · Dividend
Board of Directors of the Company at its meeting held on February 28, 2013 has recommended dividend at 20% viz., Rs 2.00 per share for the year ended December 31, 2012.
May 2012
21 May · Dividend
Dividend payout date will be May 30, 2012, subject to the approval of dividends by the shareholders of the Company at the ensuing Annual General Meeting on May 25, 2012.
Feb 2012
27 Feb · Dividend
Board of Directors of the Company at its meeting held on February 27, 2012 has recommended dividend at 20% viz., Rs 2.00 per share for the year ended December 31, 2011.
May 2011
12 May · Dividend
Dividend payout date will be June 08, 2011, subject to the approval of dividends by the shareholders of the Company at the ensuing Annual General Meeting on May 30, 2011.
Feb 2011
24 Feb · Dividend
Board of Directors of the Company at its meeting held on February 24, 2011 has recommended dividend at 15% viz., Rs 1.50 per share for the year ended December 31, 2010.
Feb 2010
24 Feb · Dividend
Board of Directors of the Company at their meeting held on February 24, 2010 has recommended dividend at 15% viz., Rs.1.50/- per share for the year ended December 31, 2009.
Jan 2007
29 Jan · Dividend
The Board of Directors has recommended a dividend of 20% (Rs. 2/- per equity share of Rs. 10/- each) for the year ended December 31, 2006